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About 2 million fracture-fixation devices are inserted annually in United
States and implant-related infections with multi-resistant bacteria are one
of the major problems of orthopaedic surgery. The average cost of combined
medical and surgical treatment is estimated at US$15,000. Multi-resistant
microorganisms like methicillin resistant Staphylococcus aureus (MRSA) and
Pseudomonas aeruginosa causes serious device related infections and they
produce biofilm layer which mainly protects them from systemic antibiotics
and host defense. Although glycopeptide antibiotics are used as the first line
therapy in this clinical setting, they were poorly effective as monotherapy in
osteomyelitis. To destroy the biofilm layer and achieve high success rate in
treatment, different strategies and methods were investigated in experi-
mental animal studies. Local application of specific bacteriophages (viruses
which destroy bacteria), combination of different kind of antibiotics, addi-
tion of local antibiotic delivery systems (ceramics, biodegradable implants)
and application of different therapeutic modalities such as hyperbaric oxy-
gen seem promising. Also, the diagnostic value of some indicators, like
serum RANK-L level, is discussed in this workshop.i.org/10.1016/j.jot.2016.06.004SpeakersSpeaker 1: Vancomycin containing PLLA/b-TCP
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